Markets and Markets, Aug 2011, Pages: 278
, toxicogenomics, genomics, drug discovery, and others.
On the basis of types:
- DNAmicroarrays, lab on chip, protein microarrays, other arrays (cell arrays and tissue arrays)
On the basis of geography
TriMark Publications, July 2011, Pages: 335
Detection Systems
3.6.1.2 Use of DNAMicroarrays and Biochips for Gene Expression Profiles in BWAs
3.6.1.3 Advantages and Disadvantages of Host Gene Expression Profiling as a Biothreat Detection
3
Venture Planning Group, Dec 2011, Pages: 250
and market shares for major suppliers.
The report also examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews
Venture Planning Group, Dec 2011, Pages: 243
and market shares for major suppliers.
The report also examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews
Venture Planning Group, Dec 2011, Pages: 242
and market shares for major suppliers.
The report also examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews
Venture Planning Group, Dec 2011, Pages: 243
market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews features and operating characteristics of automated analyzers
Business Insights, Nov 2011, Pages: 168
of MDx tests
Migration of MDx out of corelabs
Emergence of POC MDx platforms
MDx market characteristics
The global MDx market
Changing competitive landscape
Changing MDx regulation
Changing reimbursement
Markets and Markets, Nov 2010, Pages: 311
(DNAmicroarrays, lab on a chip, proteomics microarrays)
- Bioinformatics
- Proteomics (2DGE, two hybrid systems, isotope encoding and activity based assays)
- RNAi (siRNA, miRNA, ddRNAi, short
Venture Planning Group, Dec 2011, Pages: 249
and market shares for major suppliers.
The report also examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews
Venture Planning Group, Dec 2011, Pages: 278
; as well as sales and market shares for major suppliers.
The report also examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis
Fuji-Keizai USA, Inc., Sep 2009, Pages: 184
non-infectious diseases such as chronic diseases and diseases of aging. However, they still operate largely outside of core medical practice today – which is the doctor’s office and hospital lab
Fuji-Keizai USA, Inc., Sep 2009, Pages: 184
non-infectious diseases such as chronic diseases and diseases of aging. However, they still operate largely outside of core medical practice today – which is the doctor’s office and hospital lab
Venture Planning Group, Dec 2011, Pages: 248
and market shares for major suppliers.
The report also examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews
Venture Planning Group, Dec 2011, Pages: 243
and market shares for major suppliers.
The report also examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews
Venture Planning Group, Sep 2011, Pages: 248
and market shares for major suppliers.
The report also examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews
Axis Research Mind, Nov 2011, Pages: 342
discovery, DNA amplification, forensic identification, gene therapy and diagnosis. Freshly developed PCR Instruments for detecting most of the life threatening diseases also signal positive demand growth
Axis Research Mind, Nov 2011, Pages: 644
discovery, DNA amplification, forensic identification, gene therapy and diagnosis. Freshly developed PCR Instruments for detecting most of the life threatening diseases also signal positive demand growth
